Abstract
In idiopathic pulmonary fibrosis (IPF), home monitoring experiences are limited, not yet real-time available nor implemented in daily care. We evaluated feasibility and potential barriers of a new home monitoring program with real-time wireless home spirometry in IPF. Ten patients with IPF were asked to test this home monitoring program, including daily home spirometry, for four weeks. Measurements of home and hospital spirometry showed good agreement. All patients considered real-time wireless spirometry useful and highly feasible. Both patients and researchers suggested relatively easy solutions for the identified potential barriers regarding real-time home monitoring in IPF.
Highlights
Idiopathic pulmonary fibrosis (IPF) is a progressive, devastating disease with a poor prognosis [1]
Few studies using daily handheld spirometry have been performed in patients with IPF [2, 3]
These studies showed that home spirometry in IPF is feasible, may allow for better disease prediction and decrease sample size for future trials [2, 3]
Summary
Idiopathic pulmonary fibrosis (IPF) is a progressive, devastating disease with a poor prognosis [1]. In IPF, home monitoring experiences are limited and not yet implemented in daily care. Few studies using daily handheld spirometry have been performed in patients with IPF [2, 3]. These studies showed that home spirometry in IPF is feasible, may allow for better disease prediction and decrease sample size for future trials [2, 3]. Earlier studies using home spirometry in interstitial lung diseases used paper-based collection or central read-out of Forced Vital Capacity (FVC) results [2–4]. This limits possibilities to control quality of measurements, or respond directly to FVC decline or non-adherence. We assessed feasibility of a pre-developed home monitoring program in IPF [5], integrated with real-time,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have